Digital payments and fintech company Novatti Group (ASX: NOV) has added a few more Tier 1 partners to their payments network with Google Pay and Samsung Pay now supporting Novatti-issued Visa credit cards. The ability for users to be able to make these digital payments through their smartphones and smartwatches is particularly attractive to potential
Read More
Leading allied healthcare company Healthia (ASX: HLA) is set to significantly increase their services and national footprint with the $43 million acquisition of optometry group The Optical Company and their 41 clinics. The acquisition is a horizontal expansion for Healthia which has primarily operated in the podiatry and physiotherapy sectors while also owning iOrthotics, Australia’s
Read More
Biopharma company Imugene (ASX: IMU) is now on their way towards commercialisation of their lung cancer treatment with approval from the US Food and Drug Administration (FDA) to commence human trials. With the project name PD1-Vaxx in the US, the approval enables Imugene to commence recruiting patients for a clinical trial of the treatment on
Read More
Australian pharmaceuticals company Medical Developments (ASX: MVP) is set to renew their international expansion targets with greater control having taken back the distribution rights from Mundipharma in both Europe and Australia for their flagship ‘green whistle’ pain reliever – Penthrox. The decision to take back the European distribution rights to 27 countries was made in
Read More
Who will win the 2020 Melbourne Cup? In a year that has been ravaged by the pandemic, racing has been the shining light of Australian sport which will culminate in the running of the Melbourne Cup. For months, questions had been raised as to whether the race could be run, whether the international runners would
Read More
As one of the big market moves through October in the small caps space, The Sentiment caught up with Crowd Media Chairman, Steven Schapera after CM8 shares rose 57.6% through October, closing at $0.041 having started the month at $0.026. In the interview, Schapera discusses where he sees value in Crowd Media and his vision
Read More